1 Introduction Short interfering ribonucleic acid (siRNA) downregulates the expression of targeted, disease-driving genes [1] by binding to the RNA-induced silencing complex (RISC) in the cytoplasm. Therefore, following endocytosis, escape from the endo-lysosomal pathway is essential to achieve a therapeutic effect [2]. A broad range of strategies has been developed to formulate potent nanoparticles for nucleic acid delivery [3, 4], including the use of polycationic polymers [5, 6].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Florian
Contact Florian, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack